Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study describes the first three days of SARS-CoV-2 infection in an ALI model of proximal airway epithelium

Researchers evaluated the initial three days of SARS-CoV-2 infection via scRNAseq dataset in humanized in vitro model.

3 Feb 2022

Evaluating vaccine effectiveness and determining differences across demographic and clinical risk factors of COVID-19

Researchers assessed the effectiveness of COVID-19 vaccines against the manifestations of SARS-CoV-2 symptoms across different cohorts.

3 Feb 2022

A relative COVID-19 survival analysis

Researchers from the University of California Riverside, Texas A & M University, Washington University, and the Medical College of Georgia have been investigating the risks of death by age due to COVID-19 infection compared to deaths by other causes in Hubei province, China.

3 Feb 2022

Red foxes susceptible to SARS-CoV-2 infection

Working towards the aim to determine the SARS-CoV-2 susceptibility of common wildlife species, the researchers in the United States have found that red fox (Vulpes vulpes) can experimentally become infected with SARS-CoV-2 and can shed virus in its oral and nasal secretions.

3 Feb 2022

Study results strongly support COVID mRNA vaccine boosters for nursing home residents

Researchers evaluate the vaccine effectiveness of mRNA booster dose in nursing home residents who completed the primary series of mRNA vaccination.

2 Feb 2022

Nanoparticle vaccine effective against eight SARS-CoV-2 variants in non-human primates

Researchers demonstrate that SARS-CoV-2 RBD-based nanoparticle vaccine induces neutralizing antibodies against SARS-CoV-2 variants.

2 Feb 2022

Antigenic map of SARS-CoV-2 variants reveals amino acid substitutions that govern immune escape and immunodominance

Researchers use antigenic cartography to analyze cross-reactivity patterns of eight groups of human sera on a panel of SARS-CoV-2 variants.

2 Feb 2022

Analysis of SARS-CoV-2 Omicron variant-associated travel restrictions worldwide

Researchers evaluate the travel restrictions placed by nations worldwide following the emergence of the SARS-CoV-2 Omicron variant.

2 Feb 2022

Omicron variant's 'milder' outcomes may be due to more population immunity

The SARS-CoV-2 Omicron variant's "milder" outcomes are likely due to more population immunity compared to earlier waves of the pandemic rather than the virus's properties, according to a paper by William Hanage, associate professor of epidemiology and co-director of the Center for Communicable Disease Dynamics at Harvard T.H. Chan School of Public Health, and Roby Bhattacharyya, assistant professor at Massachusetts General Hospital and Harvard Medical School and associate member at the Broad Institute of MIT and Harvard.

2 Feb 2022

Booster dose of Covaxin vaccine candidate neutralizes Omicron and Delta variants

Researchers evaluate the neutralization potential of sera samples from subjects boosted with the Covaxin against the SARS-CoV-2 Omicron variant.

2 Feb 2022

New evidence that positive framing could improve COVID vaccine uptake globally

Researchers applied message framing techniques to the side effects associated with the AstraZeneca, Pfizer, and Moderna COVID-19 vaccines.

2 Feb 2022

UK's world-leading human challenge study provides new insights into mild SARS-CoV-2 infections

Findings from the UK's world-leading human challenge study provide new insights into mild infections with SARS-CoV-2 in healthy young adults.

2 Feb 2022

NIAID's new pandemic preparedness efforts aim to characterize prototype and priority pathogens

As the global COVID-19 pandemic continues into its third year, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is focusing on preparing for a range of other viral threats that could cause a public health emergency.

2 Feb 2022

Combined treatment strategy essential to minimize lung sequelae in COVID-19 patients

A combined treatment strategy targeting SARS-CoV-2 symptoms and severe lung tissue injury is essential to minimize lung sequelae- chronic complications resulting from COVID-19 infection, according to a review published this week in Clinical Microbiology Reviews, a journal of the American Society for Microbiology.

2 Feb 2022

New tool could help detect geographical hotspots for mental health problems caused by COVID

A new proof of concept tool that allows the tracking and location of people’s emotions and stresses on social media in real-time has been proposed.

2 Feb 2022

Study discovers how long-term memory T cells are formed after SARS-CoV-2 exposure

Exposure to SARS-CoV-2 by infection or vaccination generates immune cells that provide long-term immunity. These long-lived memory T cells play a key role in preventing severe cases of Covid-19. Researchers at the University of Zurich have now discovered how these memory T cells form.

2 Feb 2022

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study describes the first three days of SARS-CoV-2 infection in an ALI model of proximal airway epithelium

Evaluating vaccine effectiveness and determining differences across demographic and clinical risk factors of COVID-19

A relative COVID-19 survival analysis

Red foxes susceptible to SARS-CoV-2 infection

Study results strongly support COVID mRNA vaccine boosters for nursing home residents

Nanoparticle vaccine effective against eight SARS-CoV-2 variants in non-human primates

Antigenic map of SARS-CoV-2 variants reveals amino acid substitutions that govern immune escape and immunodominance

Analysis of SARS-CoV-2 Omicron variant-associated travel restrictions worldwide

Omicron variant's 'milder' outcomes may be due to more population immunity

Booster dose of Covaxin vaccine candidate neutralizes Omicron and Delta variants

New evidence that positive framing could improve COVID vaccine uptake globally

UK's world-leading human challenge study provides new insights into mild SARS-CoV-2 infections

NIAID's new pandemic preparedness efforts aim to characterize prototype and priority pathogens

Combined treatment strategy essential to minimize lung sequelae in COVID-19 patients

New tool could help detect geographical hotspots for mental health problems caused by COVID

Study discovers how long-term memory T cells are formed after SARS-CoV-2 exposure

Researchers discover mechanism behind loss of smell in people with COVID-19

Exploring protection via a 4th dose of BNT162b2 against SARS-CoV-2 Omicron variant in Israel

SARS-CoV-2 omicron variant shown to replicate less efficiently in human lungs

Researchers explore SARS-CoV-2 seroprevalence in a school community in Switzerland

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in